SCHEMBL9609427

SCHEMBL9609427

O=c1c2ccccc2n(CCO)c2ccc([S+](c3cc(F)c(F)c(F)c3)c3cc(F)c(F)c(F)c3)cc12

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.42
▸ POLB P06746 3/20 0.42
▸ ATM Q13315 2/20 0.42
▸ RXFP1 Q9HBX9 2/20 0.41
▸ SMN1; SMN2 Q16637 5/20 0.40
▸ ALDH1A1 P00352 4/20 0.39
▸ HPGD P15428 2/20 0.39
▸ HTT P42858 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ RCE1 Q9Y256 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ GLA P06280 2/20 0.38
▸ ABCB1 P08183 3/20 0.37
▸ PTGES O14684 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ P2RX4 Q99571 1/20 0.36
▸ MARK4 Q96L34 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9609422 0.84 P2RX4 (0.58) MAPTSMN1; SMN2ALDH1A1KDM4EP2RX4
SCHEMBL9609404 0.84 KCNA3 (0.43) MAPTPOLBRXFP1SMN1; SMN2ALDH1A1
SCHEMBL9609426 0.81 P2RX4 (0.45) MAPTPOLBRXFP1SMN1; SMN2ALDH1A1
SCHEMBL9609397 0.77 ATM (0.50) MAPTPOLBATMRXFP1ALDH1A1
SCHEMBL31124810 0.76 ALDH1A1 (0.60) MAPTPOLBATMSMN1; SMN2ALDH1A1
SCHEMBL9609425 0.74 HDAC6 (0.41) MAPTPOLBATMRXFP1SMN1; SMN2
SCHEMBL9609399 0.73 GLA (0.62) POLBALDH1A1HPGDHTTTDP1
SCHEMBL9609419 0.71 P2RX4 (0.47) MAPTPOLBRXFP1SMN1; SMN2ALDH1A1
SCHEMBL9609428 0.71 ATM (0.62) MAPTPOLBATMALDH1A1HPGD
SCHEMBL9609400 0.71 ALDH1A1 (0.59) MAPTPOLBSMN1; SMN2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9073854-B2 Aromatic sulfonium salt compound ADEKA CORPORATION (JP) 2015-07-07 — — US disclosed
US-20120136155-A1 AROMATIC SULFONIUM SALT COMPOUND ADEKA CORPORATION (JP) 2012-05-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120136155-A1 AROMATIC SULFONIUM SALT COMPOUND F12, ASIC1, SPIN1 MAPT 1744/4885POLB 1192/4885ATM 1864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback